Rabbit Anti-Human IgG H&L preadsorbed (ab7155)
Key features and details
- Rabbit Anti-Human IgG H&L preadsorbed
- Host species: Rabbit
- Suitable for: WB, IHC-P, ICC/IF, IP, ELISA
製品の概要
-
製品名
Rabbit Anti-Human IgG H&L preadsorbed
IgG 二次抗体 製品一覧 -
由来種
Rabbit -
ターゲット生物種
Human -
特異性
No reaction was observed against Mouse Serum Proteins. Specificity was confirmed using ELISA minimal cross reaction against Mouse IgG.
-
アプリケーション
適用あり: WB, IHC-P, ICC/IF, IP, ELISAmore details -
吸着処理血清
Mouse more details -
免疫原
Human IgG whole molecule
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle. -
バッファー
Preservative: 0.01% Sodium azide
Constituents: 0.88% Sodium chloride, 0.42% Potassium phosphate -
Concentration information loading...
-
精製度
Affinity purified -
特記事項(精製)
This product was prepared from monospecific antiserum by immunoaffinity chromatography using Human IgG coupled to agarose beads followed by solid phase adsorption(s) to remove any unwanted reactivities. -
ポリ/モノ
ポリクローナル -
研究分野
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab7155の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
WB |
1/10000 - 1/50000.
|
|
IHC-P |
1/1000 - 1/10000.
|
|
ICC/IF |
Use at an assay dependent concentration.
|
|
IP |
Use at an assay dependent concentration.
|
|
ELISA |
1/75000 - 1/500000.
|
特記事項 |
---|
WB
1/10000 - 1/50000. |
IHC-P
1/1000 - 1/10000. |
ICC/IF
Use at an assay dependent concentration. |
IP
Use at an assay dependent concentration. |
ELISA
1/75000 - 1/500000. |
プロトコール
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
データシートおよび資料
-
SDS download
-
Datasheet download
参考文献 (2)
ab7155 は 2 報の論文で使用されています。
- Calzavarini S et al. Platelet protein S limits venous but not arterial thrombosis propensity by controlling coagulation in the thrombus. Blood 135:1969-1982 (2020). PubMed: 32276277
- Yoshimura N et al. Development of a C1q-immobilized (Cim) assay to measure total antibodies to infliximab and its clinical relevance in patients with inflammatory bowel disease. Cytokine 120:54-61 (2019). PubMed: 31003189